Literature DB >> 14625453

Increased motivation for self-administered cocaine after escalated cocaine intake.

Neil E Paterson1, Athina Markou.   

Abstract

Escalation in cocaine self-administration is hypothesized to involve increased motivation to consume cocaine. The present study determined the effects of escalated cocaine self-administration in rats on the cocaine dose-response function under a progressive ratio schedule. Two groups of rats were allowed to self-administer cocaine under a fixed ratio schedule, for 1 h (ShA; n = 7) or 6 h (LgA; n = 6) per day. The subjects were then allowed to self-administer five doses of cocaine (0, 0.031, 0.063, 0.125 and 0.25 mg/infusion) under a progressive ratio schedule. The dose-response function was shifted upwards in the LgA compared to the ShA group. In conclusion, the present data suggest that escalation in cocaine self-administration is associated with a significant increase in the incentive motivational value of self-administered cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625453     DOI: 10.1097/00001756-200312020-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  92 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats.

Authors:  YueQiang Xue; Jeffery D Steketee; WenLin Sun
Journal:  Eur J Neurosci       Date:  2012-02-06       Impact factor: 3.386

3.  Incentive and dopamine sensitization produced by intermittent but not long access cocaine self-administration.

Authors:  Alex B Kawa; Alec C Valenta; Robert T Kennedy; Terry E Robinson
Journal:  Eur J Neurosci       Date:  2019-05-02       Impact factor: 3.386

4.  Escalated cocaine "binges" in rats: enduring effects of social defeat stress or intra-VTA CRF.

Authors:  Michael Z Leonard; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2017-07-18       Impact factor: 4.530

5.  Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats.

Authors:  Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-07-21       Impact factor: 3.533

6.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

7.  Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction.

Authors:  Serge H Ahmed; Robert Lutjens; Lena D van der Stap; Dusan Lekic; Vincenzo Romano-Spica; Marisela Morales; George F Koob; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

8.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

9.  Intermittent access to preferred food reduces the reinforcing efficacy of chow in rats.

Authors:  Pietro Cottone; Valentina Sabino; Luca Steardo; Eric P Zorrilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

10.  Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.